Q3 2024 Earnings Call Transcript November 6, 2024 Operator: Good day, and welcome to the Vertex Inc. Third Quarter 2024 ...

Hello and thanks for joining us to discuss Vertex Inc third quarter financial results. I'm Joe Crivelli, Vice President, Investor Relations, David DiStefano, our President and CEO and John Schwab. Our ...

OpenPhenom is a non-commercial, publicly available foundation model built on microscopy data that has set the new "gold ...

As a wave of patent expirations encroaches upon many of the world’s top drugmakers, companies will need to be diligent in ...

CREC will receive delivery of Trinasolar’s Vertex N 720W Series of n-type tunnel oxide passivated contact (TOPCon) modules.

Vertex AI, and more. Wipro’s Google Gemini Experience Zone will offer a wide range of benefits to enterprises looking to fast ...

Neurocrine Biosciences, Inc.'s potential for growth in the biopharma sector is strong despite recent setbacks, making its ...

Biotech industry leaders added to the Board of Directors, bringing deep expertise in drug discovery, neuroscience clinical development, and ...

Vertex has initiated the MAD portion of the Phase 1/2 study ... including statements regarding Entrada’s strategy, future operations, prospects and plans, objectives of management, the validation and ...

Q4 2024 Earnings Call Transcript November 12, 2024 Operator: Good morning, and welcome to the RMR Group Fiscal Fourth Quarter ...

Vertex Pharma has teamed up with Orum Therapeutics ... Discover how AI is transforming the pharma commercial strategy. Unlock real-time insights & actions from data. Click here for more.